Recent Advances in Pulmonary Hypertension
نویسندگان
چکیده
582 It is estimated that >140 million people live above 2500 m in various regions of the world. There are many challenges to living at high altitude, but chronic exposure to alveolar hypoxia is prominent among them. Inspired Po 2 falls from ≈150 mm Hg at sea level to ≈100 mm Hg at 3000 m and 43 mm Hg on the summit of Everest (8400 m). The body responds by hyperventilating, increasing resting heart rate, and stimulating red cell production in an attempt to maintain the oxygen content of arterial blood at or above sea level values. However, hypoxic pulmonary vasoconstriction (HPV) and vascular remodeling, together with increased erythropoiesis, place an increased pressure load on the right ventricle (RV). How well healthy humans adapt to hypoxia depends on their rate of ascent to altitude, the severity and duration of their exposure, and their genetic background.
منابع مشابه
Recent Trends in the Management of Pulmonary Hypertension
Context. Pulmonary hypertension is a common clinical problem encountered in day-to-day practice. Drug therapy forms the backbone of management and appropriate drug selection is based upon the underlying causes. The options available are widening with availability of newer therapeutic agents and thus it becomes necessary to be updated with the recent developments. Objective. To review the existi...
متن کاملPulmonary arterial hypertension.
Pulmonary hypertension is a complex and multidisciplinary disorder. The classification of pulmonary hypertension includes 5 groups. Pulmonary arterial hypertension is a rare disorder that can be idiopathic or heritable in nature, or associated with other conditions, such as scleroderma or congenital heart disease. The recent decades have realized advances in the treatment of this once devastati...
متن کاملRecent advances in the treatment of pulmonary hypertension.
PURPOSE OF REVIEW Pulmonary hypertension is a debilitating life-threatening disease of all ages. The long-term prognosis can be dismal despite maximal medical therapy. There have been significant advances in our understanding of the pathobiology and genetics of this disease, and novel pharmacological approaches appear to offer promising alternatives to conventional therapy. Anesthesiologists ha...
متن کاملRecent Advances in Pulmonary Hypertension
2189 Pulmonary arterial hypertension (PAH) is a disease characterized by progressive remodeling of the distal pulmonary arteries, resulting in the loss of vascular cross-sectional area and elevated pulmonary vascular resistance (PVR). Without intervention, PAH is usually progressive, leading to right heart failure and death. Since the first reported studies of calcium channel blockers >30 years...
متن کاملImproving survival in pulmonary arterial hypertension.
M ore than 50 yrs ago, DRESDALE et al. [1] reported a series of 39 patients with unexplained pulmonary hypertension and coined the term ‘‘primary pulmonary hypertension’’ to describe the condition, a term that has been revised to ‘‘idiopathic pulmonary arterial hypertension’’ in the most recent classification [2]. Idiopathic pulmonary arterial hypertension is a disease of the small pulmonary ar...
متن کاملFamilial primary pulmonary hypertension.
O insights into a disease are gained by studying the exceptional cases, the outliers. For the population with primary pulmonary hypertension (PPH), it is the patients with the familial or hereditary form that are the outliers, representing only 6 percent of the recent NHLBI PPH Registry population.' However, with recent advances in molecular biology and genetic analysis, the familial population...
متن کامل